BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2431533)

  • 1. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
    Seamonds B; Yang N; Anderson K; Whitaker B; Shaw LM; Bollinger JR
    Urology; 1986 Dec; 28(6):472-9. PubMed ID: 2431533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
    Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
    Oesterling JE
    J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma.
    Huang CL; Brassil D; Rozzell M; Schellhammer PF; Wright GL
    Prostate; 1993; 23(3):201-12. PubMed ID: 7694265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) in the management of 500 prostatic patients.
    Guillet J; Role C; Duc AT; François H
    Am J Clin Oncol; 1988; 11 Suppl 2():S61-2. PubMed ID: 2468274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
    Ahmann FR; Schifman RB
    J Urol; 1987 Mar; 137(3):431-4. PubMed ID: 2434667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
    Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC
    Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medically significant concentrations of prostate-specific antigen in serum assessed.
    Bernstein LH; Rudolph RA; Pinto MM; Viner N; Zuckerman H
    Clin Chem; 1990 Mar; 36(3):515-8. PubMed ID: 1690092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.
    Ferro MA; Barnes I; Roberts JB; Smith PJ
    Br J Urol; 1987 Jul; 60(1):69-73. PubMed ID: 2441790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J
    Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.